Biostage, Inc. Common Stock
BSTG
BSTG was delisted on the 5th of October, 2017.
30 hedge funds and large institutions have $2.13M invested in Biostage, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
6% less funds holding
Funds holding: 32 → 30 (-2)
45% less capital invested
Capital invested by funds: $3.86M → $2.13M (-$1.73M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$55.3K |
| 2 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$27.8K |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$11.3K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$10.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$132K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$41K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$40K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$39.8K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$35.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
28
Creative Planning
Overland Park,
Kansas
| $1K | +$1.13K | +1,000 | New |
|
29
Citigroup
New York
| $1K | +$1.78K | +1,568 | New |
|
|
30
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$39.8K | -35,101 | -99% |
|
|
BCM
31
Bridgeway Capital Management
Houston,
Texas
| – | -$41K | -28,525 | Closed |
|
|
32
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$40K | -28,250 | Closed |
|
|
ARTA
33
A.R.T. Advisors
New York
| – | -$31K | -21,833 | Closed |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| – | -$9K | -6,167 | Closed |
|
BSTG Hedge Fund Activity: Q3 2015 in Review
30 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q3 2015, worth a combined $2.13M — down 45% from $3.86M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BSTG and 2 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 8 added.
The largest buyer was Renaissance Technologies, adding an estimated $55.3K. The largest seller was Sio Capital Management, cutting an estimated $132K.
- 30 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q3 2015, down from 32 in Q2 2015.
- Funds reported $2.13M of Biostage, Inc. Common Stock stock for Q3 2015, down 45% quarter-over-quarter.
- 2 funds opened new Biostage, Inc. Common Stock positions in Q3 2015 and 4 closed out, a net change of -2 holders.
- The largest Biostage, Inc. Common Stock buyer in Q3 2015 was Renaissance Technologies, an estimated $55.3K added.
- The largest Biostage, Inc. Common Stock seller in Q3 2015 was Sio Capital Management, an estimated $132K sold.
Based on aggregated 13F filings for Q3 2015.